2seventy bio, Inc.
TSVT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -62.3% | 9.7% | 67.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 40.4% | 83.1% | 71.3% | 76.9% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -260% | -205.6% | -274.7% | -545% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -151.2% | -216.7% | -277.8% | -506.6% |
| EPS Diluted | -1.1 | -4.42 | -7.13 | -11.71 |
| % Growth | 75.1% | 38% | 39.1% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |